title: Post-prandial lipid levels for assessing target goal achievement in type 2 diabetic patients taking statin.
abstract: It is inconvenient to perform serum lipid analysis in fasting state in diabetic patients with drug treatment. In patients with statin treatment and Asian diet, it has not been clearly known whether non-fasting values could be used for the clinical decision making in diabetic patients. In this study, fasting and post-prandial plasma lipid profiles of hospitalized type 2 diabetic patients taking statin, were measured in whom standard diabetic breakfast in traditional Korean style were provided. In repeated-measures ANOVA, there were no significant differences among fasting, post-prandial 2 and 4 hr low-density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol values. When compared to fasting levels, both post-prandial 2 hr and 4 hr LDL cholesterol levels were misclassified as not achieved target goal only in 4% of patients. Post-prandial HDL cholesterol matched with fasting values in women, without exception. In conclusion, the fasting and post-prandial LDL and HDL cholesterol levels are not significantly different each other and can be used in the assessment of achieving target goal in type 2 diabetes taking statin after Korean diet.
authors.affiliation: Department of Internal Medicine, Maryknoll Medical Center, Korea.
authors.forename: Mikyung
authors.initials: M
authors.lastname: Kim
authors.forename: Jihye
authors.initials: J
authors.lastname: Suk
authors.forename: Hyunjung
authors.initials: H
authors.lastname: Kim
authors.forename: Hyesuk
authors.initials: H
authors.lastname: Jung
authors.forename: Taeik
authors.initials: T
authors.lastname: Kim
authors.forename: Jeonghyun
authors.initials: J
authors.lastname: Park
mesh_terms: D000368:Aged; D008076:Cholesterol, HDL / Q000097:blood*; D008078:Cholesterol, LDL / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy; D004032:Diet; D005215:Fasting; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007723:Korea; D008297:Male; D008875:Middle Aged; D019518:Postprandial Period; D011247:Pregnancy
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors